Ocuphire Pharma
global partnership with for ophthalmic solution million fully funded development and commercialization for all indications million in regulatory and sales milestones first milestone payment of million on approval for pharmacologically induced mydriasis indication tiered double digit royalties through | Ocuphire Pharma
Company
Deck Type
Deck date
November 2023
Slide
33 of 42
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Presentation
August 2023
global partnership with for million funding for potentially all and commercialization for all indications globally million in regulatory and sales milestones first potential million milestone payment on approval in tiered double digit royalties through | Ocuphire Pharma
Investor Presentation
May 2023
global partnership with for | Ocuphire Pharma
Related slides by other companies
Deezer
Results
September 2022
key a | Deezer
Shopify
Investor Presentation
March 2024
snapshot millions countries ory be at | Shopify
Melrose
Investor Presentation
March 2022
the world in powder metallurgy | Melrose
BlackSky
SPAC
September 2021
global construction company solution | BlackSky
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io